Study Phase III Study to Assess the Efficacy and Safety of SOTB07 in Asthma Patients
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the efficacy and safety of SOTB07 in asthma patients
by observing changes FEV1 (% predicted) as the primary efficacy endpoint after oral
administration of SOTB07 200mg, 400mg, placebo for 12 weeks.